H.R. 5534 · 116th Congress
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
113 cosponsors · 80 D, 33 R
5 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
What it does: CRS summary · Reported to House, Part I · Dec 24, 2020
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
This bill indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage. Under current law, Medicare coverage is limited to 36 months following a transplant.
The Government Accountability Office must report on the bill's implementation.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Latest action (Dec 24, 2020): Placed on the Union Calendar, Calendar No. 570.
Policy area: Health · Origin: House · Introduced: Dec 23, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.